论文部分内容阅读
目的:探究中医辨证论治联合化疗对肺结核患者治疗效果、毒副反应及治疗依从性的影响。方法:选取72例肺结核患者作为观察对象,随机分为观察组和对照组,每组36例患者。对照组采用西药抗痨治疗,观察组采取中医辨证论治联合化疗进行治疗,对比两组患者的治疗效果。结果:观察组患者总有效率为97.2%,显著优于对照组的83.3%,差异具有统计学意义(P<0.05);观察组患者的胃肠道不良反应发生率及毒副反应发生率都显著低于对照组,差异具有统计学意义(P<0.05)。结论:通过中医辨证论治联合化疗进行的治疗干预,增强肺结核患者战胜疾病的信心,显著降低胃肠道不良反应及毒副反应,提升患者的依从性,疗效显著,具有临床应用价值。
Objective: To explore the effect of syndrome differentiation of traditional Chinese medicine combined with chemotherapy on the treatment of patients with pulmonary tuberculosis, side effects and treatment compliance. Methods: Seventy-two patients with pulmonary tuberculosis were selected as observational subjects and randomly divided into observation group and control group with 36 patients in each group. The control group was treated with western medicine anti-tuberculosis. The observation group was treated with TCM syndrome differentiation and chemotherapy combined with chemotherapy, and the treatment effect was compared between the two groups. Results: The total effective rate in the observation group was 97.2%, which was significantly better than that in the control group (83.3%), the difference was statistically significant (P <0.05). The incidence of gastrointestinal adverse reactions and the incidence of adverse reactions in the observation group were both Significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion: The therapeutic intervention by TCM syndrome differentiation and chemotherapy combined with chemotherapy can enhance the confidence of patients with pulmonary tuberculosis to overcome the disease, significantly reduce gastrointestinal adverse reactions and side effects, and improve patient compliance with significant therapeutic effect and clinical value.